NCT05335967Completed
Effectiveness Evaluation of a Self-management Program for Prostate Cancer Survivors
Development and Effectiveness Evaluation of a Self-management Program for Prostate Cancer Survivors
Source: ClinicalTrials.gov · Last updated 3 Jan 2025
Brief summary (registry, in English)
Objectives: This project aims to develop a self-management program for survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy and determine its effectiveness. Methods: The investigators will develop a self-management program and conduct a study on survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy. And the investigators will test the effectiveness of the self-management program. After completing a pretest, participants will be randomly assigned to the experimental or control group. The self-management group will receive the self-management program for 12 weeks, whereas the information group will receive an information package on a healthy diet. Posttests will be administered 12 and 16 weeks after the pretest. The study variables will include physical symptoms and bothers, cancer-related self-efficacy, social participation, demoralization, and resilience.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 85 (actual)
- First submitted
- 4 Apr 2022
- Start date
- 20 May 2022
- Primary completion date
- 31 Jul 2024
- Lead sponsor
- National Taipei University of Nursing and Health Sciences
- Diseases
- Prostate cancer
- NCT number
- NCT05335967
What you commit to
- Study type: Interventional
- Participants enrolled: 85
- From 20 May 2022 to the primary completion date, 31 Jul 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Prostate cancer survivors will be excluded if they had one or more of the following:
- A request, with the consideration of family members, that the medical team not tell the patient about the diagnosis or condition of the disease
- A history of psychiatric illness, such as dementia, depression; schizophrenia, or bipolar disorder
- Suffer from other types of cancer and actively undergoing treatment
Who the study is looking for
- Prostate cancer survivors will include if they fit the following:
- Received radical prostatectomy and suffering from urinary incontinence for at least one week
- Eastern Cooperative Oncology Group 0-1 point, able to walk entirely independently
- Have a smartphone or a tablet with a wireless network
- Their intimate partner or one of the family members willing to learn together
- Agreed to participate in the study and completed the informed consent form
Age in the registry: 20 years to 80 years · Sex: Male · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chang Gung Memorial Hospital at Keelung Coordinator of this site? Confirm its status | Keelung | Taiwan | Unknown status |
| Chang Gung Memorial Hospital at Linkou Coordinator of this site? Confirm its status | Taoyuan | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.